Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$25.8 - $34.61 $182,380 - $244,658
-7,069 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$17.65 - $28.05 $11,825 - $18,793
670 Added 10.47%
7,069 $195,000
Q1 2020

May 15, 2020

SELL
$15.19 - $29.51 $71,165 - $138,254
-4,685 Reduced 42.27%
6,399 $114,000
Q4 2019

Feb 14, 2020

SELL
$17.17 - $25.95 $8,894 - $13,442
-518 Reduced 4.46%
11,084 $278,000
Q3 2019

Nov 14, 2019

BUY
$17.84 - $22.69 $48,346 - $61,489
2,710 Added 30.48%
11,602 $207,000
Q2 2019

Aug 14, 2019

SELL
$22.0 - $31.78 $23,078 - $33,337
-1,049 Reduced 10.55%
8,892 $196,000
Q4 2018

Feb 14, 2019

BUY
$23.09 - $37.69 $229,537 - $374,676
9,941 New
9,941 $230,000

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $2.47B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Fullerton Fund Management CO Ltd. Portfolio

Follow Fullerton Fund Management CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fullerton Fund Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Fullerton Fund Management CO Ltd. with notifications on news.